GATA4 and lung carcinoma: In order to validate the clinical relevance of our findings, we searched database from Oncomine and found that the GATA4 mRNA level was significantly lower in lung cancer samples than paired normal tissues (Fig. 6b), consistent with earlier reports that the promoter region of GATA4 was methylated in 67% of lung cancer samples25.